FindTrial
Sign In

Adebrelimab + Apatinib

DRUG5 trials

Sponsors

Qilu Hospital of Shandong University, Wei Zhou, Beijing Chest Hospital, Second Affiliated Hospital of Nanchang University, Song Peng

Conditions

Carcinoma, HepatocellularHepatocellular Carcinoma Non-resectableLimited-stage Small Cell Lung Cancer (LS-SCLC)Neuroendocrine TumorsUnresectable Locally Advanced Non-small Cell Lung Cancer

Phase 2

Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
RecruitingNCT06454578
Qilu Hospital of Shandong UniversityCarcinoma, Hepatocellular
Start: 2024-07-24End: 2027-06-30Target: 30Updated: 2024-08-01
Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis
Active, not recruitingNCT06700421
Wei ZhouUnresectable Locally Advanced Non-small Cell Lung Cancer
Start: 2024-08-13End: 2026-12-31Target: 32Updated: 2024-11-22
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
Not yet recruitingNCT06764368
Beijing Chest HospitalNeuroendocrine Tumors
Start: 2025-01-01End: 2028-06-01Target: 39Updated: 2025-01-08
Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Enrolling by invitationNCT06773156
Second Affiliated Hospital of Nanchang UniversityLimited-stage Small Cell Lung Cancer (LS-SCLC)
Start: 2024-11-01End: 2030-08-01Target: 37Updated: 2025-01-14
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy
Not yet recruitingNCT07192848
Song PengHepatocellular Carcinoma Non-resectable
Start: 2025-09-30End: 2027-06-30Target: 47Updated: 2025-09-25